Powering the development of breakthrough therapies
Window Therapeutics is a Boston-based biopharmaceutical company discovering and developing transformational therapeutics for cancer and other life-threatening diseases. The company's proprietary BAM (Bottle-brush-Analogue-Macromonomer) technology platform, derived from over a decade of research at MIT, enables next-generation antibody-drug conjugates (ADCs) and polymer-based therapeutics with applications across oncology, fibrosis, autoimmune, and infectious disease areas.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountNo funding data available yet.
Know something? Help us improve our data.
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
Clinical-stage biopharma developing precision medicines for cancer and other serious diseases usi...
Biotech venture firm and therapeutics accelerator that invests at seed stage and acts as a drug d...
China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...
Uses AI to analyze natural chemistry and accelerate discovery of new medicines for biopharma and ...
